Agios Pharma (AGIO) PT Raised to $91 at Needham & Company
Tweet Send to a Friend
Needham & Company analyst Chad Messer raised the price target on Agios Pharma (NASDAQ: AGIO) to $91.00 (from $89.00) while ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
